Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Mar;34(3):695–700. doi: 10.1128/jcm.34.3.695-700.1996

Two distinct human parainfluenza virus type 1 genotypes detected during the 1991 Milwaukee epidemic.

K J Henrickson 1, L L Savatski 1
PMCID: PMC228872  PMID: 8904440

Abstract

The extent of genetic and antigenic variation found in a population of human parainfluenza virus type 1 (HPIV-1) during a single local epidemic was investigated. Fifteen HPIV-1 strains isolated from children in 1991 were analyzed. Nucleotide sequence variation in the hemagglutinin-neuraminidase protein (HN) gene demonstrated two distinct genotypes (genotypes C and D). Unique patterns were identified involving 62 nucleotide and 10 amino acid positions. These patterns represented 40% of all mutations within the HN gene. The remaining mutations were randomly distributed, and 74% involved only one (55%) or two isolates. Genotypes were statistically different from each other at both the nucleotide (P = 0.001) and amino acid (P = 0.001) levels and demonstrated unique potential N-linked glycosylation patterns. Thirty-eight monoclonal antibodies (MAbs) made to four different viral proteins (22 HN, 2 fusion [F], 1 phosphoprotein, and 13 nucleoprotein) (originating from two different genotypes [genotypes A and D]) were compared for their ability to bind to the clinical isolates in enzyme-linked immunosorbent assays (ELISAs) and hemagglutinin-inhibition (HI) assays. Twenty-one MAbs bound well to all clinical isolates in ELISAs and HI assays. The remaining 17 MAbs showed variation in all four structural proteins. Three HN MAbs demonstrated genotype C- and D-specific antigenic and neutralization differences. Evolutionary analysis using parsimony methods confirmed the differences between the two genotypes. No differences in either clinical presentation or disease severity between the two genotypes were found. Geographically localized HPIV-1 epidemics can be caused by at least two distinct genotypes with minor but specific antigenic changes. The clinical and immunologic roles of HPIV-1 genotypes have not been determined.

Full Text

The Full Text of this article is available as a PDF (207.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrose M. R., Hetherington S. V., Watson A. S., Scroggs R. A., Portner A. Molecular evolution of the F glycoprotein of human parainfluenza virus type 1. J Infect Dis. 1995 Apr;171(4):851–856. doi: 10.1093/infdis/171.4.851. [DOI] [PubMed] [Google Scholar]
  2. Anderson L. J., Hendry R. M., Pierik L. T., Tsou C., McIntosh K. Multicenter study of strains of respiratory syncytial virus. J Infect Dis. 1991 Apr;163(4):687–692. doi: 10.1093/infdis/163.4.687. [DOI] [PubMed] [Google Scholar]
  3. Anderson L. J., Hierholzer J. C., Tsou C., Hendry R. M., Fernie B. F., Stone Y., McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis. 1985 Apr;151(4):626–633. doi: 10.1093/infdis/151.4.626. [DOI] [PubMed] [Google Scholar]
  4. Bause E. Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes. Biochem J. 1983 Feb 1;209(2):331–336. doi: 10.1042/bj2090331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coelingh K. V., Winter C. C. Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites. J Virol. 1990 Mar;64(3):1329–1334. doi: 10.1128/jvi.64.3.1329-1334.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deshpande K. L., Portner A. Structural and functional analysis of Sendai virus nucleocapsid protein NP with monoclonal antibodies. Virology. 1984 Nov;139(1):32–42. doi: 10.1016/0042-6822(84)90327-1. [DOI] [PubMed] [Google Scholar]
  7. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387–395. doi: 10.1093/nar/12.1part1.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henrickson K. J., Kingsbury D. W., van Wyke Coelingh K. L., Naeve C. W., Portner A. Neutralizing epitopes of human parainfluenza virus type 3 are conformational and cannot be imitated by synthetic peptides. Vaccine. 1991 Apr;9(4):243–249. doi: 10.1016/0264-410x(91)90107-h. [DOI] [PubMed] [Google Scholar]
  9. Henrickson K. J., Kuhn S. M., Savatski L. L. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis. 1994 May;18(5):770–779. doi: 10.1093/clinids/18.5.770. [DOI] [PubMed] [Google Scholar]
  10. Henrickson K. J., Kuhn S. M., Savatski L. L., Sedmak J. Recovery of human parainfluenza virus types one and two. J Virol Methods. 1994 Feb;46(2):189–205. doi: 10.1016/0166-0934(94)90103-1. [DOI] [PubMed] [Google Scholar]
  11. Henrickson K. J. Lower respiratory viral infections in immunocompetent children. Adv Pediatr Infect Dis. 1994;9:59–96. [PubMed] [Google Scholar]
  12. Henrickson K. J. Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates. J Infect Dis. 1991 Dec;164(6):1128–1134. doi: 10.1093/infdis/164.6.1128. [DOI] [PubMed] [Google Scholar]
  13. Henrickson K. J., Savatski L. L. Genetic variation and evolution of human parainfluenza virus type 1 hemagglutinin neuraminidase: analysis of 12 clinical isolates. J Infect Dis. 1992 Nov;166(5):995–1005. doi: 10.1093/infdis/166.5.995. [DOI] [PubMed] [Google Scholar]
  14. Hetherington S. V., Watson A. S., Scroggs R. A., Portner A. Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages. J Infect Dis. 1994 Feb;169(2):248–252. doi: 10.1093/infdis/169.2.248. [DOI] [PubMed] [Google Scholar]
  15. Johnson P. R., Spriggs M. K., Olmsted R. A., Collins P. L. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5625–5629. doi: 10.1073/pnas.84.16.5625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Komada H., Kusagawa S., Orvell C., Tsurudome M., Nishio M., Bando H., Kawano M., Matsumura H., Norrby E., Ito Y. Antigenic diversity of human parainfluenza virus type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies. J Gen Virol. 1992 Apr;73(Pt 4):875–884. doi: 10.1099/0022-1317-73-4-875. [DOI] [PubMed] [Google Scholar]
  17. Komada H., Tsurudome M., Ueda M., Nishio M., Bando H., Ito Y. Isolation and characterization of monoclonal antibodies to human parainfluenza virus type 4 and their use in revealing antigenic relation between subtypes 4A and 4B. Virology. 1989 Jul;171(1):28–37. doi: 10.1016/0042-6822(89)90507-2. [DOI] [PubMed] [Google Scholar]
  18. McConnochie K. M., Hall C. B., Walsh E. E., Roghmann K. J. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr. 1990 Jul;117(1 Pt 1):52–62. doi: 10.1016/s0022-3476(05)82443-6. [DOI] [PubMed] [Google Scholar]
  19. Murphy B. R., Hall S. L., Kulkarni A. B., Crowe J. E., Jr, Collins P. L., Connors M., Karron R. A., Chanock R. M. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 1994 Apr;32(1):13–36. doi: 10.1016/0168-1702(94)90059-0. [DOI] [PubMed] [Google Scholar]
  20. Prinoski K., Côté M. J., Kang C. Y., Dimock K. Evolution of the fusion protein gene of human parainfluenza virus 3. Virus Res. 1992 Jan;22(1):55–69. doi: 10.1016/0168-1702(92)90089-r. [DOI] [PubMed] [Google Scholar]
  21. Storch G. A., Anderson L. J., Park C. S., Tsou C., Dohner D. E. Antigenic and genomic diversity within group A respiratory syncytial virus. J Infect Dis. 1991 Apr;163(4):858–861. doi: 10.1093/infdis/163.4.858. [DOI] [PubMed] [Google Scholar]
  22. Sugawara K., Kitame F., Nishimura H., Nakamura K. Operational and topological analyses of antigenic sites on influenza C virus glycoprotein and their dependence on glycosylation. J Gen Virol. 1988 Mar;69(Pt 3):537–547. doi: 10.1099/0022-1317-69-3-537. [DOI] [PubMed] [Google Scholar]
  23. Swierkosz E. M., Erdman D. D., Bonnot T., Schneiderheinze C., Waner J. L. Isolation and characterization of a naturally occurring parainfluenza 3 virus variant. J Clin Microbiol. 1995 Jul;33(7):1839–1841. doi: 10.1128/jcm.33.7.1839-1841.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tsurudome M., Nishio M., Komada H., Bando H., Ito Y. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. Virology. 1989 Jul;171(1):38–48. doi: 10.1016/0042-6822(89)90508-4. [DOI] [PubMed] [Google Scholar]
  25. Urquhart G. E., Kennedy D. H., Ariyawansa J. P. Croup associated with parainfluenza type 1 virus: two subpopulations. Br Med J. 1979 Jun 16;1(6178):1604–1604. doi: 10.1136/bmj.1.6178.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yamaguchi R., Iwai H., Ueda K. Variation of virulence and other properties among Sendai virus strains. Microbiol Immunol. 1988;32(2):235–240. doi: 10.1111/j.1348-0421.1988.tb01383.x. [DOI] [PubMed] [Google Scholar]
  27. Yurlova T. I., Sverkunova M. V., Furaeva V. A., Sukhinin V. P., Shitikova G. S., Fedová D., Kunzová L. Studies of natural population variability of parainfluenza viruses during their epidemic circulation. Acta Virol. 1991 Jan;35(1):64–70. [PubMed] [Google Scholar]
  28. van Wyke Coelingh K. L., Winter C., Murphy B. R. Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus. Virology. 1985 Jun;143(2):569–582. doi: 10.1016/0042-6822(85)90395-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES